Gulshat R. Gilyazova
Ufa, BA 450008, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
MiRNA-146a-A Key Player in Immunity and Diseases.
Journal: International journal of molecular sciences
Published: July 12, 2023
Treatment of Metastatic Renal Cell Carcinoma with Checkpoint Inhibitors in Clinical Practice in the Volga-Ural Region of the Eurasian Continent.
Journal: Current pharmaceutical design
Published: June 09, 2023
MicroRNA Expression Signatures in Clear Cell Renal Cell Carcinoma: High-Throughput Searching for Key miRNA Markers in Patients from the Volga-Ural Region of Eurasian Continent.
Journal: International journal of molecular sciences
Published: February 10, 2023
Exosomal miRNA-155 and miRNA-146a are promising prognostic biomarkers of the severity of hemorrhagic fever with renal syndrome.
Journal: Non-coding RNA research
Published: October 03, 2022
Exosomal miRNA-146a is downregulated in clear cell renal cell carcinoma patients with severe immune-related adverse events.
Journal: Non-coding RNA research
Published: June 10, 2022
Methylation and expression levels of microRNA-23b/-24-1/-27b, microRNA-30c-1/-30e, microRNA-301a and let-7g are dysregulated in clear cell renal cell carcinoma.
Journal: Molecular biology reports
Published: September 30, 2020
Novel MicroRNA Binding Site SNPs and the Risk of Clear Cell Renal Cell Carcinoma (ccRCC): A Case-Control Study.
Journal: Current cancer drug targets
Published: July 24, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026